If you're hoping a state law will force your insurer to cover a GLP-1, check two things first: whether your state has such a law, and whether your plan is the kind that state law can reach. For most people with job-based insurance, it isn't.
Why state mandates often don't apply to you
A few states have passed laws requiring certain plans to cover obesity treatment, including GLP-1 medications. As of September 2026 the list is short, and the rules are narrower than "all insurers must cover GLP-1s" (see the table below). If you live in one of these states, your coverage odds may be better.
The catch is that state mandates generally reach only state-regulated, fully-insured plans. They don't reach self-funded employer plans, which are regulated federally under ERISA, and ERISA preempts state insurance mandates. In KFF's 2025 Employer Health Benefits Survey, 67% of covered workers were in self-funded plans (80% at firms with 200 or more workers). So for about two out of three people with employer coverage, a state mandate doesn't apply.
Where things stand (as of September 2026)
State rules change every legislative session. Treat this as a starting point and confirm current law with your state's insurance department or a maintained tracker.
| State | What the law does | GLP-1s included? |
|---|---|---|
| North Dakota | Updated its essential-health-benefits benchmark plan (effective 2025) so individual and small-group plans cover weight-loss medication for morbid obesity. It's the only state benchmark that does so | Yes |
| Colorado | 2025 law requires large-group plans to offer enrollees the option to buy weight-loss-medication coverage | Yes, the offered option must include at least one GLP-1, but it's an opt-in rider, not automatic coverage |
| Illinois | Since July 2024, all plans in the State Employees Group Insurance Program cover GLP-1s for adults with obesity, prediabetes or gestational diabetes | Yes, but only for state workers and their dependents; it isn't a commercial-plan mandate |
| Medicaid (state programs) | As of January 2026, 13 state Medicaid fee-for-service programs cover GLP-1s for obesity; four states (California, New Hampshire, Pennsylvania and South Carolina) ended coverage on January 1, 2026 | Varies by state |
How to find out what applies to you
- Find out whether your plan is fully-insured or self-funded. Ask HR or your benefits team, or look in your plan documents for the words "self-funded" or "self-insured". This one fact decides whether a state mandate touches your plan at all.
- If your plan is fully-insured, read your state's mandate language. Mandates vary: some require obesity treatment coverage broadly, and others name anti-obesity medications specifically.
- Check Medicaid separately. State Medicaid programs set their own obesity-treatment coverage, independent of commercial mandates, and it differs a lot from state to state.
Why this matters for advocacy
State legislatures are closer to home than Congress, and constituent pressure, public testimony and local campaigns reach them more easily than federal Medicare policy. If your state doesn't mandate obesity treatment coverage, you can contact your state representative, submit public comment during a legislative session, or join a local patient advocacy effort. That work is separate from your own coverage fight, and the Medicaid cuts in January 2026 are a reminder that coverage can be taken away as well as added.
This article is general education, not medical, legal, or insurance advice. Coverage rules, appeal rights, and policy details vary by plan and location and change over time. Confirm specifics with your plan, prescriber, or a qualified advisor.